In MLL-AF9 driven acute myeloid leukaemia (AML), poor prognosis in patients correlated with expression of EMT markers and experimental downregulation of ZEB1 in AML cells inhibited the invasive capacity of this aggressive cancer [9]. Here, ZEB1 is linked to acute myeloid leukemia.